Literature DB >> 30344693

Identification of mutations in SLC4A1, GP1BA and HFE in a family with venous thrombosis of unknown cause by next-generation sequencing.

Wei-An Chang1,2, Chau-Chyun Sheu1,2,3, Kuan-Ting Liu1,3,4, Jheng-Heng Shen1,4, Meng-Chi Yen1,4, Po-Lin Kuo1.   

Abstract

Various risk factors, including high age, female gender, obesity and certain genetic defects have been linked to venous thrombosis. A Taiwanese family with venous thrombosis of unknown cause were enrolled in the present study. In this pedigree, two women without any specific underlying diseases suffered from venous thrombotic events at the same age. No specific risk factors or coagulation abnormalities were identified. The main proband's younger brother also had intestinal arterial thrombosis at 54 years of age. Therefore, it was hypothesized that familial genetic defects may be the cause of venous thrombosis within this family. Blood samples collected from certain members of this pedigree were subjected to whole-exome sequencing, and three genetic variants were identified, including a missense variant of solute carrier family 4 member 1 (SLC4A1) (c.388G>A), a deletion on glycoprotein Ib platelet α subunit (GP1BA) (c.1322_1344del23) and an insertion in the splice site of homeostatic iron regulator (HFE). To date, none of these three genetic variants have been reported to be associated with venous thrombosis, to the best of our knowledge. The present study suggests that these genetic variants of SLC4A1, GP1BA and HFE may be associated with venous thrombosis in an Asian pedigree.

Entities:  

Keywords:  glycoprotein Ib platelet α subunit; homeostatic iron regulator; next-generation sequencing; solute carrier family 4 member 1; venous thrombosis; whole-exome sequencing

Year:  2018        PMID: 30344693      PMCID: PMC6176166          DOI: 10.3892/etm.2018.6693

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

Review 1.  Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

Authors:  Magnus Ingelman-Sundberg
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

2.  Novel genetic abnormalities in Bernard-Soulier syndrome in India.

Authors:  Shahnaz Ali; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Ann Hematol       Date:  2013-09-01       Impact factor: 3.673

3.  A Novel Homozygous c.800C>G Substitution in GP1BA Exon 2 in a Kuwaiti Family with Bernard-Soulier Syndrome.

Authors:  Abdul Shlebak; Anthony Poles; Richard Manning; Shaikha Almuhareb; Josu De La Funte; Mike Mitchell; Geoff Lucas
Journal:  Acta Haematol       Date:  2015-05-28       Impact factor: 2.195

4.  Genetic background and risk of postpartum haemorrhage: results from an Italian cohort of 3219 women.

Authors:  E Biguzzi; F Franchi; B Acaia; W Ossola; U Nava; E M Paraboschi; R Asselta; F Peyvandi
Journal:  Haemophilia       Date:  2014-10-21       Impact factor: 4.287

5.  Massive pulmonary embolism and acute limb ischaemia in a patient of hereditary spherocytosis and patent foramen ovale.

Authors:  S K Agarwal; A S Binbrek; James A Thompson; Safia A P Siddiqui
Journal:  Heart Lung Circ       Date:  2010-07-08       Impact factor: 2.975

Review 6.  Familial thrombophilia: genetic risk factors and management.

Authors:  M Makris; F R Rosendaal; F E Preston
Journal:  J Intern Med Suppl       Date:  1997

7.  Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran.

Authors:  A Afrasiabi; A Lecchi; A Artoni; M Karimi; E Ashouri; F Peyvandi; P M Mannucci
Journal:  Platelets       Date:  2007-09       Impact factor: 3.862

Review 8.  New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.

Authors:  Bo Wang; Li-Ping Yang; Xiao-Zhuang Zhang; Shui-Qing Huang; Mark Bartlam; Shu-Feng Zhou
Journal:  Drug Metab Rev       Date:  2009       Impact factor: 4.518

9.  Structure and Function of SLC4 Family [Formula: see text] Transporters.

Authors:  Ying Liu; Jichun Yang; Li-Ming Chen
Journal:  Front Physiol       Date:  2015-12-01       Impact factor: 4.566

Review 10.  Thrombophilia in East Asian countries: are there any genetic differences in these countries?

Authors:  Toshiyuki Miyata; Keiko Maruyama; Fumiaki Banno; Reiko Neki
Journal:  Thromb J       Date:  2016-10-04
View more
  2 in total

1.  The genetics of venous thromboembolism: a systematic review of thrombophilia families.

Authors:  Yu Zhang; Zhu Zhang; Shi Shu; Wenquan Niu; Wanmu Xie; Jun Wan; Zhenguo Zhai; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

2.  The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-Approaching with Next-Generation Sequencing and Bioinformatics.

Authors:  Wei-An Chang; Chia-Min Chen; Chau-Chyun Sheu; Ssu-Hui Liao; Ya-Ling Hsu; Ming-Ju Tsai; Po-Lin Kuo
Journal:  Molecules       Date:  2020-11-21       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.